Quality-Adjusted Life Years
"Quality-Adjusted Life Years" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A measurement index derived from a modification of standard life-table procedures and designed to take account of the quality as well as the duration of survival. This index can be used in assessing the outcome of health care procedures or services. (BIOETHICS Thesaurus, 1994)
| Descriptor ID |
D019057
|
| MeSH Number(s) |
E05.318.740.100.500.700 N01.224.935.530.700
|
| Concept/Terms |
Quality-Adjusted Life Years- Quality-Adjusted Life Years
- Life Year, Quality-Adjusted
- Life Years, Quality-Adjusted
- Quality-Adjusted Life Year
- Year, Quality-Adjusted Life
- Years, Quality-Adjusted Life
- Quality Adjusted Life Years
- QALY
Adjusted Life Years- Adjusted Life Years
- Adjusted Life Year
- Life Year, Adjusted
- Life Years, Adjusted
- Year, Adjusted Life
- Years, Adjusted Life
|
Below are MeSH descriptors whose meaning is more general than "Quality-Adjusted Life Years".
Below are MeSH descriptors whose meaning is more specific than "Quality-Adjusted Life Years".
This graph shows the total number of publications written about "Quality-Adjusted Life Years" by people in this website by year, and whether "Quality-Adjusted Life Years" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 3 | 3 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 7 | 7 |
| 2003 | 3 | 2 | 5 |
| 2004 | 1 | 2 | 3 |
| 2005 | 1 | 2 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 3 | 3 |
| 2008 | 1 | 4 | 5 |
| 2009 | 0 | 6 | 6 |
| 2010 | 0 | 3 | 3 |
| 2011 | 2 | 4 | 6 |
| 2012 | 4 | 5 | 9 |
| 2013 | 1 | 3 | 4 |
| 2014 | 2 | 3 | 5 |
| 2015 | 1 | 5 | 6 |
| 2016 | 1 | 7 | 8 |
| 2017 | 1 | 1 | 2 |
| 2018 | 0 | 4 | 4 |
| 2019 | 1 | 3 | 4 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 4 | 5 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 4 | 4 |
| 2024 | 3 | 1 | 4 |
| 2025 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Quality-Adjusted Life Years" by people in Profiles.
-
Gil LA, Asti L, Chen HF, Saito JM, Pattisapu P, Deans KJ, Minneci PC. Cost-Effectiveness of Nonoperative Management vs Upfront Laparoscopic Appendectomy for Pediatric Uncomplicated Appendicitis for 1 Year. J Am Coll Surg. 2025 Mar 01; 240(3):288-298.
-
Combs JC, Yamasaki MU, Dougherty M, Hunkler K, Osmundsen EB, Roura-Monllor J, Stillman RJ, Hill MJ, Devine K, DeCherney AH, Nelson RE, O'Brien JE. Comparing gestational carrier with uterine transplantation in uterine-factor infertility: a cost-effectiveness analysis. Fertil Steril. 2025 Jul; 124(1):134-143.
-
Sharp ASP, Kinnaird T, Curzen N, Ayyub R, Alfonso JE, Mamas MA, Vanden Bavi?re H. Cost-effectiveness of intravascular ultrasound-guided percutaneous intervention in patients with acute coronary syndromes: a UK perspective. Eur Heart J Qual Care Clin Outcomes. 2024 Dec 19; 10(8):677-688.
-
Pietzsch JB, Geisler BP, Garner AM, Ryschon AM, Gray WA, Fujihara M, Schneider PA. Clinical and economic implications of focal dissection treatment following percutaneous transluminal angioplasty of the superficial femoral artery: an exploratory analysis based on the TOBA II Study. J Comp Eff Res. 2025 01; 14(1):e240055.
-
Weintraub WS, Kolm P, Dolman S, Alva M, Bhatt DL, Zhang Z. Cost-Effectiveness of Sotagliflozin in SOLOIST-WHF. JACC Heart Fail. 2024 09; 12(9):1600-1610.
-
Willke RJ, Pizzi LT, Rand LZ, Neumann P. The Value of the Quality-Adjusted Life Years. Value Health. 2024 06; 27(6):702-705.
-
Weintraub WS, Bhatt DL, Zhang Z, Dolman S, Boden WE, Bress AP, Bellows BK, Derington CG, Philip S, Steg G, Miller M, Brinton EA, Jacobson TA, Tardif JC, Ballantyne CM, Kolm P. Cost-Effectiveness of Icosapent Ethyl in REDUCE-IT USA: Results From Patients Randomized in the United States. J Am Heart Assoc. 2024 01 02; 13(1):e032413.
-
Hoveidaei AH, Nakhostin-Ansari A, Namdari S, Hosseini-Asl SH, Khonji MS, Selk-Ghaffari M, Pouramini A, LaPorte DM. Increasing Burden of Upper-Extremity Fractures in the Middle East and North Africa (MENA): A 30-Year Analysis of the Epidemiology and Causes of Injuries. J Bone Joint Surg Am. 2024 Feb 21; 106(4):323-336.
-
Brown GC, Brown MM, Monigle MC. Cost-Utility Analysis of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration. Ophthalmol Retina. 2024 05; 8(5):431-446.
-
Felfeli T, Teja B, Miranda RN, Simbulan F, Sridhar J, Sander B, Naimark DM. Cost-Utility of Rhegmatogenous Retinal Detachment Repair With Pars Plana Vitrectomy, Scleral Buckle, and Pneumatic Retinopexy: A Microsimulation Model. Am J Ophthalmol. 2023 Nov; 255:141-154.